Artificial Intelligence (AI) - From promise to practice
FROM ALGORITHMS TO BIOLOGY
AI and Computational Modeling Approaches for Dose Optimisation During Drug Development
Reimagining Pharmacovigilance
Beyond Trial and Error
EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
Engineering the Future of Pneumococcal Conjugate Vaccines (PCV)
PhD, Chemical and Biotechnology, Savitribai Phule Pune University. Manager-Manufacturing, Inventprise Inc
Walmik Karbhari Gaikwad PhD is a seasoned biopharmaceutical expert with years in vaccine RD and manufacturing His PhD research pioneered costeffective processes for pneumococcal conjugate vaccines holds scholarly publications international patents and serves on editorial boards Based in Seattle currently works on cGMPcompliant process development and production at Inventprise Inc
Articles
Decoding Antisense Oligonucleotides: Mechanisms, Applications, and Future Directions
Antisense oligonucleotides ASOs constitute a class of synthetic nucleic acidbased therapeutics that target RNA molecules with high specificity These short chemically modified strands bind complementary RNA sequences thereby modulating gene expression at the posttranscriptional level ASOs offer precise interventions for diseases driven by aberrant gene products including genetic disorders neurodege...
Research Insights
Analysis of Prognostic Factors in Critically Ill Patients with COVID-19
The Coronavirus Disease COVID caused by the SARSCoV virus emerged in late and rapidly evolved into a global pandemic impacting healthcare systems and economies worldwide
Case Studies
Unusual Drug Response And Hemodynamics In VA – ECMO : A Drug Case Study
Abstract Maintaining higher sedation in patients undergoing ECMO therapy is crucial Currently no definite sedation strategy has been proposed in the literature as the pharmacokinetics of the medications in these patients is still not clear We would like to report a case of a patient with uncontrollable diverse clinical response to medications during arteriovenou
Techno Trends
Pear Therapeutics Developed reSET-A™ PDT Product Candidate for Alcohol Use Disorder (AUD)
Pear therapeutics developed new reSETA PDT product candidate for the treatment of alcohol use disorder AUD PDTsare new therapeutic class designed with software to directly treat disease Similar to traditional medicines PDTs are developed and tested
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
Innovative Approaches for Safer and More Effective Healthcare
Dani is a content strategist passionate about crafting compelling narratives. With a knack for blending creativity and data-driven insights, she specialises in developing content that engages and converts.
The Role of Genomics in Shaping the Future of Medicine
Smita Agrawal holds a PhD in Chemical Engineering from the University of California, Berkeley. She has over 20 years of research experience in stem cell biology, neuroscience, immunology, genomics, oncology and real-world data. She currently serves as an independent consultant, offering strategic guidance and insights to life sciences companies on genomics, AI, and health care data applications.
Homeopathic Science
Aditya Dilipkumar Patil pursed B.H.M.S. and MD (Hom) from Bharati Vidyapeeth (Deemed to be University) Homoeopathic Medical College and Post Graduate Research Centre, Pune. He is currently working as Assistant Professor in Department of Homoeopathic Pharmacy at Dr.D.Y.Patil Homoeopathic Medical College and Research Centre, Pimpri, Pune 411018. He is a member of Chandrabhaga Charitable trust since 2017 and Life member of Moredada Charitable Trust, Nashik, Department of Herbal Medicine since 2018. He was working as Senior Research Fellow in Central Council for Research in Homoepathy (CCRH under Ministry of AYUSH). His main research work focuses on Evidenced based medicine, Diabetes, preclinical studies (In-vitro & In-vivo), nanoparticle etc.
Parth Sanjeev Aphale pursed B.H.M.S. from Dhondumama Sathe Homoeopathic Medical College and Research Centre, Pune and MD (Hom) from Foster Development Homoeopathic Medical College, Aurangabad. He is currently working as Professor in Department of Homoeopathic pharmacy at Dr.D.Y.Patil Homoeopathic Medical College and Research Centre, Pimpri, Pune 411018.
Dharmendra Basudeo Sharma pursed B.H.M.S. from Dhondumama Sathe Homoeopathic Medical College and Research Centre, Pune and MD (Hom) from University of Rajasthan and Ph.D from Maharashtra University of Health Science (MUHS). He is currently working as Principal and Head of Institute at Dr.D.Y.Patil Homoeopathic Medical College and Research Centre, Pimpri, Pune 411018.
Artificial Intelligence
Assistant Professor, Department of Pharmaceutics, L. M.College of Pharmacy
L. M.College of Pharmacy
Endocrine Disrupting Compounds (EDCs)
Sintu Kumar Samanta has been working as an Assistant professor in IIIT Allahabad, India. He did Ph.D. and post-doctoral research from IIT Kharagpur and IISc Bangalore, India respectively. He is working in the area of Biochemistry and Nanobiotechnology. He published research work in several international journals and filed one Indian patent.
Pavan Kumar Gautamis presently working as a Post-Doctoral Fellow in the Department of Applied Sciences at IIIT Allahabad, India. He obtained Ph.D. from the University of Allahabad, India. His area of research is synthesis of nanoparticles for water remediation. He published his research work in many international journals.
press releasesRead more...
Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays
Monod Bio a Seattlebased AIenabled protein design company and SignalChem Biotech Inc a whollyowned subsidiary of Sino Biological Inc SZSE today announced a nonexclusive licensing agreement
Lotus Pharmaceutical Announces Favorable U.S. Appeals Court Ruling on Norwich’s Application for Generic Rifaximin
Lotus Pharmaceutical Co Ltd Taiwan Stock Exchange a leading global pharmaceutical company today announced that Norwich Pharmaceuticals Inc Norwich a wholly owned subsidiary of Alvogen
SK Biopharmaceuticals to In-License Epilepsy Drug Candidate ‘Opakalim’ Paves the Way to Launch its Second Innovative Drug Directly in the U.S.
SK Biopharmaceuticals Co Ltd wwwskbpcom CEO Donghoon Lee held a press conference on August th and announced that it has entered into an agreement to inlicense opakalim an investigational
DKSH Performance Materials Expands its Pharma Business Through the Acquisition of P.R. Chemicals in Thailand
DKSH has signed an agreement to acquire PR Chemicals Company Limited PR Chemicals a Thai distributor specialized in Active Pharmaceutical Ingredients APIs
Celltrion Expands Omlyclo® Portfolio in Europe with Launch of 300 mg Strength
Celltrion KRX today announced the launch of the mg strength of Omlyclo omalizumab a treatment for chronic spontaneous urticaria and allergic asthma in Europe With the addition
ASTRI and Saint Francis University Sign MoU to Advance AI-Enabled Biomaterials and Digital Health Innovation
The Hong Kong Applied Science and Technology Research Institute ASTRI and Saint Francis University SFU have signed a Memorandum of Understanding MoU to establish a strategic partnership focused on advancing
EventsRead more...
03 - 05
Sep 20265th MENA Congress for Rare Diseases 2026
Beach Rotana Hotel, Abu Dhabi,...
14 - 15
Sep 202616th American DDF Summit
Omni Boston Hotel at the Seapo...
14 - 16
Sep 202615 - 17
Sep 2026COPD Drug Development Summit 2026
Street, Boston, MA 02210, USA
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
22 - 23
Sep 2026PDA Advanced Parenteral Therapeutics & Quality Summit
Illume Hotel Taipei, Taiwan
28 - 01
Sep 2026Discovery on Target 2026
Boston, MA, USA
LATEST NEWSRead more...
Jazz Pharmaceuticals Announces Approval of Ziihera Regimens for Advanced HER2-Positive Gastroesophageal Cancer
Jazz Pharmaceuticals has announced that the US Food and Drug Administration FDA has approved two Ziihera zanidatamabhriibased treatment regimens for the firstline treatment of adults with unresectable
BioCryst Announces Approval of ORLADEYO for Pediatric HAE Patients
BioCryst Pharmaceuticals has announced that Japans Ministry of Health Labour and Welfare MHLW has approved ORLADEYO berotralstat for the prevention of hereditary angioedema HAE attacks in children aged to under years
Takeda Receives Approval for ORZEYFUL (oveporexton) to Treat Narcolepsy Type 1
Takeda has announced that Japans Ministry of Health Labour and Welfare MHLW has approved ORZEYFUL oveporexton for the treatment of narcolepsy type NT a form of narcolepsy associated with cataplexy in adults
Johnson & Johnson’s IMAAVY Approved in the US as First Treatment for Warm Autoimmune Haemolytic Anaemia
Johnson Johnson has announced that the US Food and Drug Administration FDA has approved IMAAVY nipocalimabaahu for the treatment of warm autoimmune haemolytic anaemia wAIHA in adults and children aged years and older who are currently or previously treated with corticosteroids
Lotus Pharmaceutical Receives PMDA Approval for Generic Pomalidomide Capsules in Japan
Lotus Pharmaceutical Co Ltd Taiwan Stock Exchange has received marketing approval in Japan for its generic pomalidomide capsules in mg mg mg and mg strengths following a review
Ultragenyx Receives U.S. FDA Approval for GENGLYCOS Gene Therapy for Glycogen Storage Disease Type Ia
Ultragenyx Pharmaceutical Inc NASDAQ RARE has received accelerated approval from the US Food and Drug Administration FDA for GENGLYCOS pariglasgene brecaparvovecopnr also known as DTX for adults and children aged eight years and older with glycogen storage disease type Ia GSDIa
